GIUSTI, RAFFAELE
 Distribuzione geografica
Continente #
NA - Nord America 450
EU - Europa 190
AS - Asia 18
AF - Africa 4
SA - Sud America 3
OC - Oceania 1
Totale 666
Nazione #
US - Stati Uniti d'America 444
IT - Italia 83
FR - Francia 51
DE - Germania 19
NL - Olanda 10
CA - Canada 6
CN - Cina 6
UA - Ucraina 5
BG - Bulgaria 4
GB - Regno Unito 4
SE - Svezia 4
ZA - Sudafrica 4
FI - Finlandia 3
IN - India 3
JP - Giappone 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
ES - Italia 1
GR - Grecia 1
HK - Hong Kong 1
ID - Indonesia 1
IE - Irlanda 1
KR - Corea 1
MK - Macedonia 1
PT - Portogallo 1
RO - Romania 1
TW - Taiwan 1
Totale 666
Città #
Santa Cruz 68
Rome 49
Fairfield 35
Ashburn 33
Seattle 24
Buffalo 20
Chicago 17
Woodbridge 16
Houston 11
Cambridge 9
Des Moines 9
New York 9
Wilmington 8
Boardman 7
Los Angeles 7
Amsterdam 6
San Diego 6
San Francisco 6
Andover 5
Ann Arbor 5
Atlanta 5
Bremen 5
Henderson 5
Las Vegas 5
Clearwater 4
Dallas 4
Paris 4
Sofia 4
Stockholm 4
Groningen 3
Helsinki 3
Milan 3
Muizenberg 3
Toronto 3
Athens 2
Frosinone 2
Pasadena 2
Providence 2
Rockville 2
San Jose 2
Shanghai 2
Venezia 2
Verona 2
Alcorcón 1
Alpharetta 1
Anzio 1
Atherstone 1
Auburn 1
Banjarnegara 1
Bari 1
Bhiwani 1
Bloomfield 1
Büdelsdorf 1
Carrollton 1
Cedar Knolls 1
Chelles 1
Costa da Caparica 1
Crugers 1
Frankfurt Am Main 1
Gangseo-gu 1
Grosseto 1
Herndon 1
Hong Kong 1
Huilong 1
Jacksonville 1
Jersey City 1
Lake Stevens 1
Laurel 1
Levallois-perret 1
Mainz 1
Manchester 1
Melbourne 1
Mountain View 1
Naas 1
New Orleans 1
Newcastle upon Tyne 1
Nola 1
Nîmes 1
Oak Lawn 1
Ottawa 1
Pontedera 1
Québec 1
Recife 1
Reston 1
Riva 1
Santiago 1
Scarborough 1
Scottsdale 1
Scranton 1
Secaucus 1
South Bend 1
Stadtlohn 1
Tempe 1
Thessaloniki 1
Timișoara 1
Trumbull 1
Verrua Po 1
Wuhan 1
Yellow Springs 1
Totale 479
Nome #
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab, file e3835322-fdd0-15e8-e053-a505fe0a3de9 88
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors. Prospective analysis from a multicentre observational trial by FICOG, file e383532c-06bc-15e8-e053-a505fe0a3de9 65
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort, file e383532e-bede-15e8-e053-a505fe0a3de9 64
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment, file e3835325-06eb-15e8-e053-a505fe0a3de9 60
Next-Generation Sequencing in Clinical Practice. Is It a Cost-Saving Alternative to a Single-Gene Testing Approach?, file e383532a-b341-15e8-e053-a505fe0a3de9 60
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting, file e3835322-d440-15e8-e053-a505fe0a3de9 59
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1, file e3835327-d2c9-15e8-e053-a505fe0a3de9 59
Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%. A multicenter study with external validation, file e383532a-0448-15e8-e053-a505fe0a3de9 48
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes, file e3835328-2476-15e8-e053-a505fe0a3de9 45
New driver alterations in non-small cell lung cancer. A narrative review, file bc05cb4f-7a7b-4011-a389-4f3bf698103b 27
Statins and immunotherapy. Togetherness makes strength The potential effect of statins on immunotherapy for NSCLC, file e383532e-a6ac-15e8-e053-a505fe0a3de9 22
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status, file e383532e-5d61-15e8-e053-a505fe0a3de9 18
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials, file 8a3582fd-e99b-4c87-b1d0-a55b310ea650 11
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%, file 592d8680-9b39-49af-8bb5-55779af2ca78 9
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients. a multicenter study of clinicians’ attitudes, file a1e692a7-582d-4aa1-83e8-1e2245f2b05f 9
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting, file e383532a-6618-15e8-e053-a505fe0a3de9 8
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden, file e3835329-7ad4-15e8-e053-a505fe0a3de9 5
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives, file a2ffb1cb-4a5c-4324-8874-5939bf90a4a8 4
Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer, file e3835318-b20f-15e8-e053-a505fe0a3de9 4
Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification, file e3835325-41ee-15e8-e053-a505fe0a3de9 4
Pharmacogenetic Approach to Toxicity in Breast Cancer Patients Treated with Taxanes, file e383531d-09c9-15e8-e053-a505fe0a3de9 3
Unexpected serious aplastic anemia from PD-1 inhibitors. beyond what we know, file e3835322-9f01-15e8-e053-a505fe0a3de9 3
Training and telemedicine: the key to the palliative medicine specialist shortage?, file 58582743-66c0-4b48-b69f-7c20a3968eeb 2
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario, file e383532e-8c1f-15e8-e053-a505fe0a3de9 2
Efficacy and safety of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis, file 19854a83-9635-4f92-aa72-7fa330c40f66 1
Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer, file 8d92376e-0b3f-4ccc-9470-dbba2639b7e4 1
KEAP1 and TP53 frame genomic, evolutionary and immunological subtypes of lung adenocarcinoma with different sensitivity to immunotherapy, file e383532d-1993-15e8-e053-a505fe0a3de9 1
Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care. a national survey, file e383532e-75bd-15e8-e053-a505fe0a3de9 1
Totale 683
Categoria #
all - tutte 1.820
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.820


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202043 3 0 7 1 2 2 2 3 10 3 7 3
2020/2021104 7 1 4 9 1 4 3 2 9 32 16 16
2021/2022174 4 3 7 2 14 7 11 10 11 20 63 22
2022/2023243 15 9 48 34 14 19 8 25 54 3 13 1
2023/2024113 4 7 8 4 20 20 11 20 11 8 0 0
Totale 683